Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Independent Prostate Cancer (AIPC)”

24 trials

Showing 20 of 24 results

Testing effectiveness (Phase 2)Study completedNCT00661492
What this trial is testing

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Who this might be right for
Androgen-independent Prostate Cancer
US Oncology Research 115
Testing effectiveness (Phase 2)Study completedNCT00291005
What this trial is testing

PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone

Who this might be right for
Prostatic Neoplasms
Sanofi 42
Testing effectiveness (Phase 2)UnknownNCT00285675
What this trial is testing

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Who this might be right for
Androgen Independent Prostate Cancer (AIPC)Non Small Cell Lung Cancer (NSCLC)
Novacea 25
Testing effectiveness (Phase 2)Study completedNCT00901342
What this trial is testing

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 104
Large-scale testing (Phase 3)Study completedNCT00065442
What this trial is testing

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Dendreon 512
Large-scale testing (Phase 3)Ended earlyNCT00273338
What this trial is testing

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Who this might be right for
Prostate Cancer
Novacea 1,200
Testing effectiveness (Phase 2)Study completedNCT00307294
What this trial is testing

Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)

Who this might be right for
Prostate Cancer
University of Pittsburgh 40
Testing effectiveness (Phase 2)Study completedNCT00087854
What this trial is testing

Study of Individualized Amonafide to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Xanthus Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00274287
What this trial is testing

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 15
Testing effectiveness (Phase 2)Study completedNCT00456989
What this trial is testing

Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Louisville 39
Testing effectiveness (Phase 2)Study completedNCT02097303
What this trial is testing

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

Who this might be right for
Prostate Cancer
Carolina Research Professionals, LLC 36
Testing effectiveness (Phase 2)Study completedNCT00634647
What this trial is testing

Satraplatin and Prednisone to Treat Prostate Cancer

Who this might be right for
Prostate CancerGenetic Polymorphism
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00182741
What this trial is testing

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00654186
What this trial is testing

Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 32
Testing effectiveness (Phase 2)Study completedNCT00599313
What this trial is testing

Phase II Sunitinib Prog Met AIPC

Who this might be right for
Metastatic Prostate Cancer
US Oncology Research 36
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Testing effectiveness (Phase 2)Study completedNCT00080678
What this trial is testing

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00683475
What this trial is testing

IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer

Who this might be right for
Prostate Cancer
Eli Lilly and Company 138
Testing effectiveness (Phase 2)Study completedNCT00110188
What this trial is testing

Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)

Who this might be right for
Prostate Cancer
Merck Sharp & Dohme LLC 39
Early research (Phase 1)Study completedNCT00424385
What this trial is testing

Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 17
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation